PDS Limited has completed the allotment of 63,750 equity shares under its Employee Stock Option Plan 2021 - Plan A, marking another milestone in its employee benefit initiatives. The Nomination and Remuneration Committee of the Board of Directors approved this allotment on February 10, 2026, benefiting employees of the company and its subsidiaries who exercised their vested stock options.

Share Allotment Details

The allotment comprises 63,750 equity shares with a face value of ₹2 each, issued to eligible employees who exercised their stock options under the ESOP scheme. The shares were allotted at exercise prices of ₹219 and ₹253.40 per share, with corresponding premiums of ₹217 and ₹251.40 per share respectively.

Impact on Share Capital

Following this allotment, the company's capital structure has been enhanced significantly. The issued, subscribed and paid-up capital increased from the existing ₹28,27,56,766 to ₹28,28,84,266. The total number of equity shares outstanding rose from 14,13,78,383 to 14,14,42,133 shares.

Regulatory Compliance and Share Characteristics

The newly allotted shares carry distinctive numbers from 14,13,78,384 to 14,14,42,133 and will be issued in demat form under ISIN number INE111Q01021. These shares will rank pari-passu with the existing equity shares of the company, ensuring equal rights and privileges for all shareholders.

The company has confirmed that no lock-in provisions apply to these shares, and they are identical in all respects to the existing equity shares. PDS Limited's shares are listed on both BSE Limited (Scrip Code: 538730) and National Stock Exchange of India Limited (Scrip Symbol: PDSL), providing liquidity options for the allottees.

ESOP Plan Background

The Employee Stock Option Plan 2021 - Plan A was originally filed with the stock exchanges on August 18, 2021, with filing numbers BSE: 136424 and NSE: 28018. This allotment represents the company's continued commitment to employee participation in its growth story through equity-based compensation structures.

PDS Limited has announced a board meeting scheduled for February 10, 2026, to review and approve the company's quarterly financial performance. The meeting will focus on approving unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.

Board Meeting Details

The company has formally notified stock exchanges about the upcoming board meeting in accordance with regulatory requirements. The meeting details are outlined below:

Trading Window Restrictions

In line with the company's internal compliance framework, PDS Limited has implemented trading window restrictions for designated persons. The company has informed its designated persons about the closure of the trading window as part of its 'Code of Internal Procedures and Conduct For Regulating, Monitoring and Reporting of Trading by Insiders including Designated Persons'.

Regulatory Compliance

The announcement demonstrates PDS Limited's adherence to regulatory requirements under SEBI guidelines. The company has formally communicated the board meeting schedule to both major stock exchanges where its shares are listed.

The notification was signed by Abhishek Kanoi, Group Legal Head & Company Secretary, with ICSI Membership No. F-9530, ensuring proper authorization and compliance with corporate governance standards.